What is it about?
According to our results, both montelukast and mometasone furoate therapies were similarly successful in treating adenoid hypertrophy. Combined therapy has no superiority over single-therapy treatment.
Featured Image
Why is it important?
According to our results, both montelukast and mometasone furoate therapies were similarly successful in the treatment of adenoid hypertrophy. Both treatment methods may separately be an alternative option to surgery depending on treatment adherence by the patients. Larger studies are warranted for dosage and duration of use.
Perspectives
Operations are decreasing.
M.D.(Assoc.Prof.) Sanem Oksan Erkan
Adana City Training and Research Hospital
Read the Original
This page is a summary of: Evaluation of the effects of montelukast, mometasone furoate, and combined therapyon adenoid size: a randomized, prospective, clinical trial with objective data, TURKISH JOURNAL OF MEDICAL SCIENCES, January 2017, The Scientific and Technological Research Council of Turkey,
DOI: 10.3906/sag-1701-179.
You can read the full text:
Contributors
The following have contributed to this page







